Treatment of hyponatremic encephalopathy.
Decaux
G
G
D001381:Azepines / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D001928:Brain Diseases, Metabolic / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007010:Hyponatremia / Q000150:complications / Q000188:drug therapy*; D007177:Inappropriate ADH Syndrome / Q000150:complications / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy; D011758:Pyrroles; D017483:Receptors, Vasopressin / Q000378:metabolism; D012965:Sodium Chloride / Q000378:metabolism; D001569:Benzodiazepines
D001381:Azepines; D001549:Benzamides; D011758:Pyrroles; D017483:Receptors, Vasopressin; D012965:Sodium Chloride; C409452:lixivaptan; D001569:Benzodiazepines